cropped color_logo_with_background.png

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

Study Purpose

This partially randomized phase I/II trial studies the side effects and the best dose of anti-endoglin monoclonal antibody TRC105 when given together with bevacizumab and to see how well they work in treating patients with glioblastoma multiforme that has come back. Monoclonal antibodies, such as anti-endoglin monoclonal antibody TRC105 and bevacizumab, may find tumor cells and help kill them. Giving anti-endoglin monoclonal antibody TRC105 together with bevacizumab may be an effective treatment for glioblastoma multiforme.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Histological confirmation of grade 3 or 4 glioma, including astrocytoma, oligodendroglioma, and mixed gliomas, as determined by pre-registration central pathology review (Phase I) - Histological confirmation of glioblastoma multiforme (grade 4 astrocytoma) as determined by pre-registration central pathology review; note: gliosarcomas and other grade 4 astrocytoma variants (e.g., giant cell) are eligible; glioblastoma (GBM) with oligodendroglial features are NOT PERMITTED in this study if they are 1p19q co-deleted; sites submitting GBM with oligodendroglial features will be asked to provide results of 1p/19q co-deletion status (Phase II) - Evidence of tumor progression by MRI or computed tomography (CT) scan following radiation therapy or following the most recent anti-tumor therapy; note: patients who have had surgical treatment at recurrence are eligible if they had a resection with measurable or non-measurable residual disease on postoperative imaging or if there is imaging evidence of disease progression as compared to the first postoperative scan.
  • - Measurable or evaluable disease by gadolinium MRI or contrast CT scan; note: patients who have had a gross total resection (GTR) are eligible on the basis of evaluable disease.
  • - Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2.
  • - Absolute neutrophil count (ANC) >= 1,500/mm^3.
  • - Platelet count >= 100,000/mm^3.
  • - White blood cells (WBC) >= 3,000/mL.
  • - Hemoglobin >= 10.0 g/dL; note: this level may be reached by transfusion.
  • - Total bilirubin =< institutional upper limit of normal (ULN) - Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< 2 x ULN.
  • - Creatinine =< ULN.
  • - Life expectancy >= 12 weeks.
  • - Negative serum pregnancy test done =< 7 days prior to registration, for women of childbearing potential only.
  • - Urine protein creatinine (UPC) ratio < 1; note: urine protein must be screened by urine analysis for UPC ratio; for UPC ratio >= 1.0, 24-hour urine protein must be obtained and the level should be < 1,000 mg for registration.
  • - Fixed or decreasing dose of corticosteroids (or no corticosteroids) >= 7 days prior to registration.
  • - Calculated glomerular filtration rate (GFR) must be >= 60 ml/min; GFR will be calculated as needed per institutional guidelines.
  • - Any number of prior chemotherapy regimens for recurrent disease (Phase I); =< 1 chemotherapy or other non-antiangiogenic regimen for recurrent disease (Phase II) - Last dose of bevacizumab >= 2 weeks prior to registration (Phase I); note: for the phase II study only, prior exposure to bevacizumab is not allowed.
  • - Surgery >= 4 weeks prior to registration.
  • - Completion of radiation therapy >= 12 weeks prior to registration and prior chemotherapy >= 4 weeks prior to registration (>= 6 weeks from nitrosourea-containing regimens) - Small molecular cell cycle inhibitors >= 2 weeks from registration.
  • - Ability to provide informed written consent.
  • - Ability to complete questionnaire(s) by themselves or with assistance.
  • - Willing to return to enrolling institution for follow-up.
  • - Willing to discontinue use of medications that inhibit platelet function >= 10 days prior to registration; aspirin at doses greater than 325 mg/day must be discontinued >= 10 days prior to registration and avoided through the study; note: nonsteroidal anti-inflammatory drug (NSAID) medications are recommended in place of aspirin; if NSAIDs or aspirin are used, histamine (H)-2 blockers and proton pump inhibitor (PPI) medications are recommended.
  • - Willing to provide mandatory blood and tissue samples for correlative research purposes (Phase I and II)

    Exclusion Criteria:

    - Any of the following: - Pregnant women.
  • - Nursing women.
  • - Men or women of childbearing potential who are unwilling to employ adequate contraception throughout the duration of the study and for at least 6 months after treatment has ended.
  • - Prior hypersensitivity to bevacizumab or toxicity requiring discontinuation of bevacizumab (Phase I) - Any prior exposure to any VEGF or VEGF inhibitor including, but not limited to, bevacizumab, cediranib, vandetanib, sunitinib, pazopanib, aflibercept, or sorafenib (Phase II) - Prior hypersensitivity to Chinese hamster ovary cell products or other recombinant human antibodies (Phase I and II) - Prior hypersensitivity to triptan derivatives (Phase I and II) - Other active malignancy =< 3 years prior to registration; exceptions: non-melanotic skin cancer or carcinoma-in-situ of the cervix; note: if there is a history of prior malignancy, they must not be receiving other specific treatment (other than hormonal therapy) for their cancer.
  • - Uncontrolled infection.
  • - Immunocompromised patients or patients known to be human immunodeficiency virus (HIV) positive and currently receiving combination antiretroviral therapy; patients known to be HIV positive, but without clinical evidence of an immunocompromised state, are eligible for this trial.
  • - Co-morbid systemic illnesses or other severe concurrent disease which, in the judgment of the investigator, would make the patient inappropriate for entry into this study or interfere significantly with the proper assessment of safety and adverse events of the prescribed regimens.
  • - Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, or psychiatric illness/social situations that would limit compliance with study requirements.
  • - History of hypertensive crisis or hypertensive encephalopathy.
  • - Clinically significant cardiovascular disease defined as follows: - Inadequately controlled hypertension (i.e., systolic blood pressure [SBP] > 160 mm Hg and/or diastolic blood pressure [DBP] > 90 mm Hg despite antihypertensive therapy) - History of cerebrovascular accident (CVA) within 6 months.
  • - Myocardial infarction or unstable angina within 6 months.
  • - New York Heart Association classification II, III, or IV cardiovascular disease.
  • - Serious and inadequately controlled cardiac arrhythmia.
  • - Significant vascular disease (i.e., aortic aneurysm, history of aortic dissection) - Clinically significant peripheral vascular disease.
  • - Evidence or history of bleeding diathesis (greater than normal risk of bleeding, i.e., hereditary hemorrhagic telangiectasia type I or HHT-1) or coagulopathy in the absence of therapeutic anti-coagulation or any hemorrhage/bleeding event > grade 3 within 4 weeks prior to registration; note: patients with full-dose anticoagulants are eligible provided the patient has been on a stable dose for at least 2 weeks of low molecular weight heparin; therapeutic Coumadin and aspirin doses > 325 mg daily are not allowed.
  • - Receiving any other investigational agent that would be considered as a treatment for the primary neoplasm.
  • - Prior treatment with TRC105.
  • - Serious or non-healing wound, active ulcer, or untreated bone fracture.
  • - History of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess =< 6 months prior to registration.
  • - History of invasive procedures defined as follows: - Major surgical procedure, open biopsy, or significant traumatic injury =< 28 days prior to registration.
  • - Anticipation of need for major surgical procedures during the study.
  • - Core biopsy =< 7 days prior to registration.
- History of significant vascular disease (i.e., aortic aneurysm requiring surgical repair, or recent peripheral arterial thrombosis) within 6 months prior to registration

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT01648348
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase 1/Phase 2
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

National Cancer Institute (NCI)
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Evanthia Galanis
Principal Investigator Affiliation Alliance for Clinical Trials in Oncology
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

NIH
Overall Status Completed
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Neoplasm
Additional Details

PRIMARY OBJECTIVES:

  • I. To establish a maximum tolerated dose (MTD) of TRC105 (anti-endoglin monoclonal antibody TRC105) combined with bevacizumab in this patient population.
(Phase I)
  • II. To assess the safety and adverse events of TRC105 in combination with bevacizumab in this patient population.
(Phase II)
  • III. To determine the efficacy of TRC105 in combination with bevacizumab in recurrent glioblastoma as measured by progression-free survival and compare it with the efficacy of bevacizumab alone in this patient population.
(Phase II) SECONDARY OBJECTIVES:
  • I. To assess the proportion of patients, who are progression free at 6 months, treated with TRC105 in combination with bevacizumab as compared to bevacizumab alone.
(Phase II)
  • II. To assess the overall survival of patients treated with TRC105 in combination with bevacizumab compared to bevacizumab alone.
(Phase II)
  • III. To compare the impact of the treatment on the patients quality of life (QOL) using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life questionnaire (QLQ)-C15-Palliative Care (PAL) and QLQ-brain neoplasm (BN)20 Patient Questionnaires.
(Phase II)
  • IV. To estimate patient recommendations for study participation to others using the Was It Worth It (WIWI) Questionnaire.
(Phase II) TERTIARY OBJECTIVES:
  • I. To evaluate the pharmacokinetics of TRC105.
(Phase I)
  • II. To evaluate the immunogenicity of TRC105.
(Phase I)
  • III. To determine the relationship between tumor biomarkers, circulating biomarkers of vascular response and vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) single-nucleotide polymorphisms (SNPs) in predicting efficacy and/or toxicity of treatment.
(Phase II)
  • IV. To assess the utility of magnetic resonance imaging (MRI) imaging including apparent diffusion coefficient (ADC) as a predictor of response and survival.
(Phase II)
  • V. To assess the utility of dynamic contrast enhanced (DCE) MRI as a predictor of response to bevacizumab with or without TRC105.
(Phase II) OUTLINE: This is a phase I dose-escalation study of anti-endoglin monoclonal antibody TRC105, followed by a randomized phase II study. Phase I (closed to accrual 1/14/14): Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1 and anti-endoglin monoclonal antibody TRC105 IV over 1-4 hours on days 8 and 11 of course 1 and days 1 and 8 of all subsequent courses. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity. Phase II: Patients are randomized to 1 of 2 treatment arms. ARM I: Patients receive bevacizumab IV over 30-90 minutes on day 1 and anti-endoglin monoclonal antibody TRC105 IV over 1-4 hours on days 8 and 11 of course 1 and days 1 and 8 of all subsequent courses. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity. ARM II: Patients receive bevacizumab as in arm
  • I. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 3 years.

Arms & Interventions

Arms

Experimental: Arm I (bevacizumab and TRC105)

Patients receive bevacizumab IV over 30-90 minutes on day 1 and anti-endoglin monoclonal antibody TRC105 IV over 1-4 hours on days 8 and 11 of course 1 and days 1 and 8 of all subsequent courses. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.

Active Comparator: Arm II (bevacizumab)

Patients receive bevacizumab as in arm I. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.

Interventions

Biological: - Anti-Endoglin Chimeric Monoclonal Antibody TRC105

Given IV

Biological: - Bevacizumab

Given IV

Other: - Laboratory Biomarker Analysis

Correlative studies

Other: - Pharmacological Study

Correlative studies

Other: - Quality-of-Life Assessment

Ancillary studies

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Little Rock, Arkansas

Status

Address

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205

Saint Jude Medical Center, Fullerton, California

Status

Address

Saint Jude Medical Center

Fullerton, California, 92835

Saint Joseph Hospital - Orange, Orange, California

Status

Address

Saint Joseph Hospital - Orange

Orange, California, 92868

Sharp Memorial Hospital, San Diego, California

Status

Address

Sharp Memorial Hospital

San Diego, California, 92123

UCSF Medical Center-Mount Zion, San Francisco, California

Status

Address

UCSF Medical Center-Mount Zion

San Francisco, California, 94115

UCSF Medical Center-Parnassus, San Francisco, California

Status

Address

UCSF Medical Center-Parnassus

San Francisco, California, 94143

Greenwich Hospital, Greenwich, Connecticut

Status

Address

Greenwich Hospital

Greenwich, Connecticut, 06830

Hartford, Connecticut

Status

Address

Smilow Cancer Hospital Care Center at Saint Francis

Hartford, Connecticut, 06105

Stamford Hospital/Bennett Cancer Center, Stamford, Connecticut

Status

Address

Stamford Hospital/Bennett Cancer Center

Stamford, Connecticut, 06904

Beebe Medical Center, Lewes, Delaware

Status

Address

Beebe Medical Center

Lewes, Delaware, 19958

Christiana Gynecologic Oncology LLC, Newark, Delaware

Status

Address

Christiana Gynecologic Oncology LLC

Newark, Delaware, 19713

Newark, Delaware

Status

Address

Delaware Clinical and Laboratory Physicians PA

Newark, Delaware, 19713

Helen F Graham Cancer Center, Newark, Delaware

Status

Address

Helen F Graham Cancer Center

Newark, Delaware, 19713

Newark, Delaware

Status

Address

Medical Oncology Hematology Consultants PA

Newark, Delaware, 19713

Regional Hematology and Oncology PA, Newark, Delaware

Status

Address

Regional Hematology and Oncology PA

Newark, Delaware, 19713

Newark, Delaware

Status

Address

Christiana Care Health System-Christiana Hospital

Newark, Delaware, 19718

Beebe Health Campus, Rehoboth Beach, Delaware

Status

Address

Beebe Health Campus

Rehoboth Beach, Delaware, 19971

Nanticoke Memorial Hospital, Seaford, Delaware

Status

Address

Nanticoke Memorial Hospital

Seaford, Delaware, 19973

Wilmington, Delaware

Status

Address

Christiana Care Health System-Wilmington Hospital

Wilmington, Delaware, 19801

Mayo Clinic in Florida, Jacksonville, Florida

Status

Address

Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980

Mount Sinai Medical Center, Miami Beach, Florida

Status

Address

Mount Sinai Medical Center

Miami Beach, Florida, 33140

Florida Hospital Orlando, Orlando, Florida

Status

Address

Florida Hospital Orlando

Orlando, Florida, 32803

Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho

Status

Address

Saint Alphonsus Cancer Care Center-Boise

Boise, Idaho, 83706

Kootenai Medical Center, Coeur d'Alene, Idaho

Status

Address

Kootenai Medical Center

Coeur d'Alene, Idaho, 83814

Kootenai Cancer Center, Post Falls, Idaho

Status

Address

Kootenai Cancer Center

Post Falls, Idaho, 83854

Kootenai Cancer Clinic, Sandpoint, Idaho

Status

Address

Kootenai Cancer Clinic

Sandpoint, Idaho, 83864

Saint Joseph Medical Center, Bloomington, Illinois

Status

Address

Saint Joseph Medical Center

Bloomington, Illinois, 61701

Illinois CancerCare-Bloomington, Bloomington, Illinois

Status

Address

Illinois CancerCare-Bloomington

Bloomington, Illinois, 61704

Illinois CancerCare-Canton, Canton, Illinois

Status

Address

Illinois CancerCare-Canton

Canton, Illinois, 61520

Memorial Hospital of Carbondale, Carbondale, Illinois

Status

Address

Memorial Hospital of Carbondale

Carbondale, Illinois, 62902

Illinois CancerCare-Carthage, Carthage, Illinois

Status

Address

Illinois CancerCare-Carthage

Carthage, Illinois, 62321

Centralia Oncology Clinic, Centralia, Illinois

Status

Address

Centralia Oncology Clinic

Centralia, Illinois, 62801

Northwestern University, Chicago, Illinois

Status

Address

Northwestern University

Chicago, Illinois, 60611

Cancer Care Center of Decatur, Decatur, Illinois

Status

Address

Cancer Care Center of Decatur

Decatur, Illinois, 62526

Decatur Memorial Hospital, Decatur, Illinois

Status

Address

Decatur Memorial Hospital

Decatur, Illinois, 62526

Crossroads Cancer Center, Effingham, Illinois

Status

Address

Crossroads Cancer Center

Effingham, Illinois, 62401

Illinois CancerCare-Eureka, Eureka, Illinois

Status

Address

Illinois CancerCare-Eureka

Eureka, Illinois, 61530

Evanston, Illinois

Status

Address

NorthShore University HealthSystem-Evanston Hospital

Evanston, Illinois, 60201

Illinois CancerCare-Galesburg, Galesburg, Illinois

Status

Address

Illinois CancerCare-Galesburg

Galesburg, Illinois, 61401

Western Illinois Cancer Treatment Center, Galesburg, Illinois

Status

Address

Western Illinois Cancer Treatment Center

Galesburg, Illinois, 61401

Glenview, Illinois

Status

Address

NorthShore University HealthSystem-Glenbrook Hospital

Glenview, Illinois, 60026

Highland Park, Illinois

Status

Address

Hematology Oncology Associates of Illinois-Highland Park

Highland Park, Illinois, 60035

Highland Park, Illinois

Status

Address

NorthShore University HealthSystem-Highland Park Hospital

Highland Park, Illinois, 60035

Presence Saint Mary's Hospital, Kankakee, Illinois

Status

Address

Presence Saint Mary's Hospital

Kankakee, Illinois, 60901

Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois

Status

Address

Illinois CancerCare-Kewanee Clinic

Kewanee, Illinois, 61443

Libertyville, Illinois

Status

Address

NorthShore Hematology Oncology-Libertyville

Libertyville, Illinois, 60048

Illinois CancerCare-Macomb, Macomb, Illinois

Status

Address

Illinois CancerCare-Macomb

Macomb, Illinois, 61455

Garneau, Stewart C MD (UIA Investigator), Moline, Illinois

Status

Address

Garneau, Stewart C MD (UIA Investigator)

Moline, Illinois, 61265

Spector, David MD (UIA Investigator), Moline, Illinois

Status

Address

Spector, David MD (UIA Investigator)

Moline, Illinois, 61265

Trinity Medical Center, Moline, Illinois

Status

Address

Trinity Medical Center

Moline, Illinois, 61265

Illinois Cancer Specialists-Niles, Niles, Illinois

Status

Address

Illinois Cancer Specialists-Niles

Niles, Illinois, 60714

Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois

Status

Address

Illinois CancerCare-Ottawa Clinic

Ottawa, Illinois, 61350

Radiation Oncology of Northern Illinois, Ottawa, Illinois

Status

Address

Radiation Oncology of Northern Illinois

Ottawa, Illinois, 61350

Illinois CancerCare-Pekin, Pekin, Illinois

Status

Address

Illinois CancerCare-Pekin

Pekin, Illinois, 61554

Pekin, Illinois

Status

Address

OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center

Pekin, Illinois, 61554

Methodist Medical Center of Illinois, Peoria, Illinois

Status

Address

Methodist Medical Center of Illinois

Peoria, Illinois, 61603

Illinois CancerCare-Peoria, Peoria, Illinois

Status

Address

Illinois CancerCare-Peoria

Peoria, Illinois, 61615

Peoria, Illinois

Status

Address

OSF Saint Francis Radiation Oncology at Peoria Cancer Center

Peoria, Illinois, 61615

OSF Saint Francis Medical Center, Peoria, Illinois

Status

Address

OSF Saint Francis Medical Center

Peoria, Illinois, 61637

Illinois CancerCare-Peru, Peru, Illinois

Status

Address

Illinois CancerCare-Peru

Peru, Illinois, 61354

Valley Radiation Oncology, Peru, Illinois

Status

Address

Valley Radiation Oncology

Peru, Illinois, 61354

Illinois CancerCare-Princeton, Princeton, Illinois

Status

Address

Illinois CancerCare-Princeton

Princeton, Illinois, 61356

Skokie, Illinois

Status

Address

Hematology Oncology Associates of Illinois - Skokie

Skokie, Illinois, 60076

Springfield, Illinois

Status

Address

Central Illinois Hematology Oncology Center

Springfield, Illinois, 62702

Springfield, Illinois

Status

Address

Southern Illinois University School of Medicine

Springfield, Illinois, 62702

Springfield Clinic, Springfield, Illinois

Status

Address

Springfield Clinic

Springfield, Illinois, 62702

Memorial Medical Center, Springfield, Illinois

Status

Address

Memorial Medical Center

Springfield, Illinois, 62781

Swansea, Illinois

Status

Address

Cancer Care Specialists of Illinois-Swansea

Swansea, Illinois, 62226

Warrenville, Illinois

Status

Address

Northwestern Medicine Cancer Center Warrenville

Warrenville, Illinois, 60555

Crown Point, Indiana

Status

Address

Michiana Hematology Oncology PC-Crown Point

Crown Point, Indiana, 46307

Elkhart Clinic, Elkhart, Indiana

Status

Address

Elkhart Clinic

Elkhart, Indiana, 46514-2098

Michiana Hematology Oncology PC-Elkhart, Elkhart, Indiana

Status

Address

Michiana Hematology Oncology PC-Elkhart

Elkhart, Indiana, 46514

Elkhart General Hospital, Elkhart, Indiana

Status

Address

Elkhart General Hospital

Elkhart, Indiana, 46515

Indianapolis, Indiana

Status

Address

Indiana University/Melvin and Bren Simon Cancer Center

Indianapolis, Indiana, 46202

Community Howard Regional Health, Kokomo, Indiana

Status

Address

Community Howard Regional Health

Kokomo, Indiana, 46904

IU Health La Porte Hospital, La Porte, Indiana

Status

Address

IU Health La Porte Hospital

La Porte, Indiana, 46350

Memorial Regional Cancer Center Day Road, Mishawaka, Indiana

Status

Address

Memorial Regional Cancer Center Day Road

Mishawaka, Indiana, 46544

Mishawaka, Indiana

Status

Address

Michiana Hematology Oncology PC-Mishawaka

Mishawaka, Indiana, 46545

Mishawaka, Indiana

Status

Address

Saint Joseph Regional Medical Center-Mishawaka

Mishawaka, Indiana, 46545

Michiana Hematology Oncology PC-Plymouth, Plymouth, Indiana

Status

Address

Michiana Hematology Oncology PC-Plymouth

Plymouth, Indiana, 46563

Reid Health, Richmond, Indiana

Status

Address

Reid Health

Richmond, Indiana, 47374

Memorial Hospital of South Bend, South Bend, Indiana

Status

Address

Memorial Hospital of South Bend

South Bend, Indiana, 46601

South Bend, Indiana

Status

Address

Michiana Hematology Oncology PC-South Bend

South Bend, Indiana, 46601

South Bend Clinic, South Bend, Indiana

Status

Address

South Bend Clinic

South Bend, Indiana, 46617

South Bend, Indiana

Status

Address

Northern Indiana Cancer Research Consortium

South Bend, Indiana, 46628

Westville, Indiana

Status

Address

Michiana Hematology Oncology PC-Westville

Westville, Indiana, 46391

Mary Greeley Medical Center, Ames, Iowa

Status

Address

Mary Greeley Medical Center

Ames, Iowa, 50010

Ames, Iowa

Status

Address

McFarland Clinic PC-William R Bliss Cancer Center

Ames, Iowa, 50010

Bettendorf, Iowa

Status

Address

Constantinou, Costas L MD (UIA Investigator)

Bettendorf, Iowa, 52722

McFarland Clinic PC-Boone, Boone, Iowa

Status

Address

McFarland Clinic PC-Boone

Boone, Iowa, 50036

Mercy Hospital, Cedar Rapids, Iowa

Status

Address

Mercy Hospital

Cedar Rapids, Iowa, 52403

Cedar Rapids, Iowa

Status

Address

Oncology Associates at Mercy Medical Center

Cedar Rapids, Iowa, 52403

Fort Dodge, Iowa

Status

Address

McFarland Clinic PC-Trinity Cancer Center

Fort Dodge, Iowa, 50501

Iowa City, Iowa

Status

Address

University of Iowa/Holden Comprehensive Cancer Center

Iowa City, Iowa, 52242

McFarland Clinic PC-Jefferson, Jefferson, Iowa

Status

Address

McFarland Clinic PC-Jefferson

Jefferson, Iowa, 50129

McFarland Clinic PC-Marshalltown, Marshalltown, Iowa

Status

Address

McFarland Clinic PC-Marshalltown

Marshalltown, Iowa, 50158

Siouxland Regional Cancer Center, Sioux City, Iowa

Status

Address

Siouxland Regional Cancer Center

Sioux City, Iowa, 51101

Mercy Medical Center-Sioux City, Sioux City, Iowa

Status

Address

Mercy Medical Center-Sioux City

Sioux City, Iowa, 51104

Saint Luke's Regional Medical Center, Sioux City, Iowa

Status

Address

Saint Luke's Regional Medical Center

Sioux City, Iowa, 51104

Cancer Center of Kansas - Chanute, Chanute, Kansas

Status

Address

Cancer Center of Kansas - Chanute

Chanute, Kansas, 66720

Cancer Center of Kansas - Dodge City, Dodge City, Kansas

Status

Address

Cancer Center of Kansas - Dodge City

Dodge City, Kansas, 67801

Cancer Center of Kansas - El Dorado, El Dorado, Kansas

Status

Address

Cancer Center of Kansas - El Dorado

El Dorado, Kansas, 67042

Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas

Status

Address

Cancer Center of Kansas - Fort Scott

Fort Scott, Kansas, 66701

Cancer Center of Kansas-Independence, Independence, Kansas

Status

Address

Cancer Center of Kansas-Independence

Independence, Kansas, 67301

Cancer Center of Kansas-Kingman, Kingman, Kansas

Status

Address

Cancer Center of Kansas-Kingman

Kingman, Kansas, 67068

Lawrence Memorial Hospital, Lawrence, Kansas

Status

Address

Lawrence Memorial Hospital

Lawrence, Kansas, 66044

Cancer Center of Kansas-Liberal, Liberal, Kansas

Status

Address

Cancer Center of Kansas-Liberal

Liberal, Kansas, 67905

Cancer Center of Kansas-Manhattan, Manhattan, Kansas

Status

Address

Cancer Center of Kansas-Manhattan

Manhattan, Kansas, 66502

Cancer Center of Kansas - McPherson, McPherson, Kansas

Status

Address

Cancer Center of Kansas - McPherson

McPherson, Kansas, 67460

Cancer Center of Kansas - Newton, Newton, Kansas

Status

Address

Cancer Center of Kansas - Newton

Newton, Kansas, 67114

Cancer Center of Kansas - Parsons, Parsons, Kansas

Status

Address

Cancer Center of Kansas - Parsons

Parsons, Kansas, 67357

Cancer Center of Kansas - Pratt, Pratt, Kansas

Status

Address

Cancer Center of Kansas - Pratt

Pratt, Kansas, 67124

Cancer Center of Kansas - Salina, Salina, Kansas

Status

Address

Cancer Center of Kansas - Salina

Salina, Kansas, 67401

Cancer Center of Kansas - Wellington, Wellington, Kansas

Status

Address

Cancer Center of Kansas - Wellington

Wellington, Kansas, 67152

Associates In Womens Health, Wichita, Kansas

Status

Address

Associates In Womens Health

Wichita, Kansas, 67208

Wichita, Kansas

Status

Address

Cancer Center of Kansas-Wichita Medical Arts Tower

Wichita, Kansas, 67208

Cancer Center of Kansas - Wichita, Wichita, Kansas

Status

Address

Cancer Center of Kansas - Wichita

Wichita, Kansas, 67214

Via Christi Regional Medical Center, Wichita, Kansas

Status

Address

Via Christi Regional Medical Center

Wichita, Kansas, 67214

Wichita, Kansas

Status

Address

Wichita NCI Community Oncology Research Program

Wichita, Kansas, 67214

Cancer Center of Kansas - Winfield, Winfield, Kansas

Status

Address

Cancer Center of Kansas - Winfield

Winfield, Kansas, 67156

Baptist Health Corbin, Corbin, Kentucky

Status

Address

Baptist Health Corbin

Corbin, Kentucky, 40701

Oncology Hematology Care Inc-Crestview, Crestview Hills, Kentucky

Status

Address

Oncology Hematology Care Inc-Crestview

Crestview Hills, Kentucky, 41017

Hardin Memorial Hospital, Elizabethtown, Kentucky

Status

Address

Hardin Memorial Hospital

Elizabethtown, Kentucky, 42701

Baptist Health Lexington, Lexington, Kentucky

Status

Address

Baptist Health Lexington

Lexington, Kentucky, 40503

Madisonville, Kentucky

Status

Address

Baptist Health Madisonville/Merle Mahr Cancer Center

Madisonville, Kentucky, 42431

Baptist Health Paducah, Paducah, Kentucky

Status

Address

Baptist Health Paducah

Paducah, Kentucky, 42003

Eastern Maine Medical Center, Bangor, Maine

Status

Address

Eastern Maine Medical Center

Bangor, Maine, 04401

Lafayette Family Cancer Center-EMMC, Brewer, Maine

Status

Address

Lafayette Family Cancer Center-EMMC

Brewer, Maine, 04412

Scarborough, Maine

Status

Address

Maine Center for Cancer Medicine-Scarborough

Scarborough, Maine, 04074

Boston, Massachusetts

Status

Address

Massachusetts General Hospital Cancer Center

Boston, Massachusetts, 02114

Dana-Farber Cancer Institute, Boston, Massachusetts

Status

Address

Dana-Farber Cancer Institute

Boston, Massachusetts, 02115

Massachusetts General Hospital, Charlestown, Massachusetts

Status

Address

Massachusetts General Hospital

Charlestown, Massachusetts, 02129

Bixby Medical Center, Adrian, Michigan

Status

Address

Bixby Medical Center

Adrian, Michigan, 49221

Hickman Cancer Center, Adrian, Michigan

Status

Address

Hickman Cancer Center

Adrian, Michigan, 49221

Saint Joseph Mercy Hospital, Ann Arbor, Michigan

Status

Address

Saint Joseph Mercy Hospital

Ann Arbor, Michigan, 48106-0995

Bronson Battle Creek, Battle Creek, Michigan

Status

Address

Bronson Battle Creek

Battle Creek, Michigan, 49017

Beaumont Hospital-Dearborn, Dearborn, Michigan

Status

Address

Beaumont Hospital-Dearborn

Dearborn, Michigan, 48124

Saint John Hospital and Medical Center, Detroit, Michigan

Status

Address

Saint John Hospital and Medical Center

Detroit, Michigan, 48236

Hurley Medical Center, Flint, Michigan

Status

Address

Hurley Medical Center

Flint, Michigan, 48502

Genesys Hurley Cancer Institute, Flint, Michigan

Status

Address

Genesys Hurley Cancer Institute

Flint, Michigan, 48503

Mercy Health Saint Mary's, Grand Rapids, Michigan

Status

Address

Mercy Health Saint Mary's

Grand Rapids, Michigan, 49503

Spectrum Health at Butterworth Campus, Grand Rapids, Michigan

Status

Address

Spectrum Health at Butterworth Campus

Grand Rapids, Michigan, 49503

Allegiance Health, Jackson, Michigan

Status

Address

Allegiance Health

Jackson, Michigan, 49201

Borgess Medical Center, Kalamazoo, Michigan

Status

Address

Borgess Medical Center

Kalamazoo, Michigan, 49001

Bronson Methodist Hospital, Kalamazoo, Michigan

Status

Address

Bronson Methodist Hospital

Kalamazoo, Michigan, 49007

West Michigan Cancer Center, Kalamazoo, Michigan

Status

Address

West Michigan Cancer Center

Kalamazoo, Michigan, 49007

Sparrow Hospital, Lansing, Michigan

Status

Address

Sparrow Hospital

Lansing, Michigan, 48912

Saint Mary Mercy Hospital, Livonia, Michigan

Status

Address

Saint Mary Mercy Hospital

Livonia, Michigan, 48154

Mercy Memorial Hospital, Monroe, Michigan

Status

Address

Mercy Memorial Hospital

Monroe, Michigan, 48162

Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan

Status

Address

Toledo Clinic Cancer Centers-Monroe

Monroe, Michigan, 48162

Mercy Health Mercy Campus, Muskegon, Michigan

Status

Address

Mercy Health Mercy Campus

Muskegon, Michigan, 49444

Lakeland Community Hospital, Niles, Michigan

Status

Address

Lakeland Community Hospital

Niles, Michigan, 49120

Saint Joseph Mercy Oakland, Pontiac, Michigan

Status

Address

Saint Joseph Mercy Oakland

Pontiac, Michigan, 48341

Lake Huron Medical Center, Port Huron, Michigan

Status

Address

Lake Huron Medical Center

Port Huron, Michigan, 48060

Spectrum Health Reed City Hospital, Reed City, Michigan

Status

Address

Spectrum Health Reed City Hospital

Reed City, Michigan, 49677

Saint Mary's of Michigan, Saginaw, Michigan

Status

Address

Saint Mary's of Michigan

Saginaw, Michigan, 48601

Lakeland Hospital, Saint Joseph, Michigan

Status

Address

Lakeland Hospital

Saint Joseph, Michigan, 49085

Marie Yeager Cancer Center, Saint Joseph, Michigan

Status

Address

Marie Yeager Cancer Center

Saint Joseph, Michigan, 49085

Munson Medical Center, Traverse City, Michigan

Status

Address

Munson Medical Center

Traverse City, Michigan, 49684

Saint John Macomb-Oakland Hospital, Warren, Michigan

Status

Address

Saint John Macomb-Oakland Hospital

Warren, Michigan, 48093

Ypsilanti, Michigan

Status

Address

Ann Arbor Hematology -Oncology Associates

Ypsilanti, Michigan, 48197

Fairview Ridges Hospital, Burnsville, Minnesota

Status

Address

Fairview Ridges Hospital

Burnsville, Minnesota, 55337

Mercy Hospital, Coon Rapids, Minnesota

Status

Address

Mercy Hospital

Coon Rapids, Minnesota, 55433

Essentia Health Cancer Center, Duluth, Minnesota

Status

Address

Essentia Health Cancer Center

Duluth, Minnesota, 55805

Duluth, Minnesota

Status

Address

Essentia Health Saint Mary's Medical Center

Duluth, Minnesota, 55805

Miller-Dwan Hospital, Duluth, Minnesota

Status

Address

Miller-Dwan Hospital

Duluth, Minnesota, 55805

Saint Luke's Hospital of Duluth, Duluth, Minnesota

Status

Address

Saint Luke's Hospital of Duluth

Duluth, Minnesota, 55805

Fairview-Southdale Hospital, Edina, Minnesota

Status

Address

Fairview-Southdale Hospital

Edina, Minnesota, 55435

Unity Hospital, Fridley, Minnesota

Status

Address

Unity Hospital

Fridley, Minnesota, 55432

Hutchinson Area Health Care, Hutchinson, Minnesota

Status

Address

Hutchinson Area Health Care

Hutchinson, Minnesota, 55350

Maplewood, Minnesota

Status

Address

Minnesota Oncology Hematology PA-Maplewood

Maplewood, Minnesota, 55109

Saint John's Hospital - Healtheast, Maplewood, Minnesota

Status

Address

Saint John's Hospital - Healtheast

Maplewood, Minnesota, 55109

Abbott-Northwestern Hospital, Minneapolis, Minnesota

Status

Address

Abbott-Northwestern Hospital

Minneapolis, Minnesota, 55407

Hennepin County Medical Center, Minneapolis, Minnesota

Status

Address

Hennepin County Medical Center

Minneapolis, Minnesota, 55415

Health Partners Inc, Minneapolis, Minnesota

Status

Address

Health Partners Inc

Minneapolis, Minnesota, 55454

New Ulm Medical Center, New Ulm, Minnesota

Status

Address

New Ulm Medical Center

New Ulm, Minnesota, 56073

North Memorial Medical Health Center, Robbinsdale, Minnesota

Status

Address

North Memorial Medical Health Center

Robbinsdale, Minnesota, 55422

Mayo Clinic, Rochester, Minnesota

Status

Address

Mayo Clinic

Rochester, Minnesota, 55905

Saint Cloud, Minnesota

Status

Address

Coborn Cancer Center at Saint Cloud Hospital

Saint Cloud, Minnesota, 56303

Saint Cloud Hospital, Saint Cloud, Minnesota

Status

Address

Saint Cloud Hospital

Saint Cloud, Minnesota, 56303

Saint Louis Park, Minnesota

Status

Address

Metro Minnesota Community Oncology Research Consortium

Saint Louis Park, Minnesota, 55416

Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota

Status

Address

Park Nicollet Clinic - Saint Louis Park

Saint Louis Park, Minnesota, 55416

Regions Hospital, Saint Paul, Minnesota

Status

Address

Regions Hospital

Saint Paul, Minnesota, 55101

United Hospital, Saint Paul, Minnesota

Status

Address

United Hospital

Saint Paul, Minnesota, 55102

Saint Francis Regional Medical Center, Shakopee, Minnesota

Status

Address

Saint Francis Regional Medical Center

Shakopee, Minnesota, 55379

Lakeview Hospital, Stillwater, Minnesota

Status

Address

Lakeview Hospital

Stillwater, Minnesota, 55082

Ridgeview Medical Center, Waconia, Minnesota

Status

Address

Ridgeview Medical Center

Waconia, Minnesota, 55387

Rice Memorial Hospital, Willmar, Minnesota

Status

Address

Rice Memorial Hospital

Willmar, Minnesota, 56201

Woodbury, Minnesota

Status

Address

Minnesota Oncology Hematology PA-Woodbury

Woodbury, Minnesota, 55125

Parkland Health Center-Bonne Terre, Bonne Terre, Missouri

Status

Address

Parkland Health Center-Bonne Terre

Bonne Terre, Missouri, 63628

Saint Francis Medical Center, Cape Girardeau, Missouri

Status

Address

Saint Francis Medical Center

Cape Girardeau, Missouri, 63703

Southeast Cancer Center, Cape Girardeau, Missouri

Status

Address

Southeast Cancer Center

Cape Girardeau, Missouri, 63703

Jefferson City, Missouri

Status

Address

Capital Region Medical Center-Goldschmidt Cancer Center

Jefferson City, Missouri, 65109

Washington University School of Medicine, Saint Louis, Missouri

Status

Address

Washington University School of Medicine

Saint Louis, Missouri, 63110

Missouri Baptist Medical Center, Saint Louis, Missouri

Status

Address

Missouri Baptist Medical Center

Saint Louis, Missouri, 63131

Sainte Genevieve, Missouri

Status

Address

Sainte Genevieve County Memorial Hospital

Sainte Genevieve, Missouri, 63670

Missouri Baptist Sullivan Hospital, Sullivan, Missouri

Status

Address

Missouri Baptist Sullivan Hospital

Sullivan, Missouri, 63080

Sunset Hills, Missouri

Status

Address

Missouri Baptist Outpatient Center-Sunset Hills

Sunset Hills, Missouri, 63127

Billings Clinic Cancer Center, Billings, Montana

Status

Address

Billings Clinic Cancer Center

Billings, Montana, 59101

Montana Cancer Consortium NCORP, Billings, Montana

Status

Address

Montana Cancer Consortium NCORP

Billings, Montana, 59101

Saint Vincent Healthcare, Billings, Montana

Status

Address

Saint Vincent Healthcare

Billings, Montana, 59101

Bozeman Deaconess Hospital, Bozeman, Montana

Status

Address

Bozeman Deaconess Hospital

Bozeman, Montana, 59715

Butte, Montana

Status

Address

Saint James Community Hospital and Cancer Treatment Center

Butte, Montana, 59701

Great Falls, Montana

Status

Address

Benefis Healthcare- Sletten Cancer Institute

Great Falls, Montana, 59405

Saint Peter's Community Hospital, Helena, Montana

Status

Address

Saint Peter's Community Hospital

Helena, Montana, 59601

Kalispell Regional Medical Center, Kalispell, Montana

Status

Address

Kalispell Regional Medical Center

Kalispell, Montana, 59901

Missoula, Montana

Status

Address

Saint Patrick Hospital - Community Hospital

Missoula, Montana, 59802

Community Medical Hospital, Missoula, Montana

Status

Address

Community Medical Hospital

Missoula, Montana, 59804

University of Nebraska Medical Center, Omaha, Nebraska

Status

Address

University of Nebraska Medical Center

Omaha, Nebraska, 68198

Concord, New Hampshire

Status

Address

New Hampshire Oncology Hematology PA-Concord

Concord, New Hampshire, 03301

Hooksett, New Hampshire

Status

Address

New Hampshire Oncology Hematology PA-Hooksett

Hooksett, New Hampshire, 03106

Laconia, New Hampshire

Status

Address

LRGHealthcare-Lakes Region General Hospital

Laconia, New Hampshire, 03246

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Status

Address

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, 03756

Camden, New Jersey

Status

Address

Cooper Hospital University Medical Center

Camden, New Jersey, 08103

Voorhees, New Jersey

Status

Address

MD Anderson Cancer Center at Cooper-Voorhees

Voorhees, New Jersey, 08043

Auburn, New York

Status

Address

Hematology Oncology Associates of Central New York-Auburn

Auburn, New York, 13021

East Syracuse, New York

Status

Address

Hematology Oncology Associates of Central New York-East Syracuse

East Syracuse, New York, 13057

Mount Sinai Hospital, New York, New York

Status

Address

Mount Sinai Hospital

New York, New York, 10029

Memorial Sloan-Kettering Cancer Center, New York, New York

Status

Address

Memorial Sloan-Kettering Cancer Center

New York, New York, 10065

Syracuse, New York

Status

Address

State University of New York Upstate Medical University

Syracuse, New York, 13210

Syracuse, New York

Status

Address

Hematology Oncology Associates of Central New York-Onondaga Hill

Syracuse, New York, 13215

Wayne Memorial Hospital, Goldsboro, North Carolina

Status

Address

Wayne Memorial Hospital

Goldsboro, North Carolina, 27534

Kinston Medical Specialists PA, Kinston, North Carolina

Status

Address

Kinston Medical Specialists PA

Kinston, North Carolina, 28501

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Status

Address

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157

Altru Cancer Center, Grand Forks, North Dakota

Status

Address

Altru Cancer Center

Grand Forks, North Dakota, 58201

Strecker Cancer Center-Belpre, Belpre, Ohio

Status

Address

Strecker Cancer Center-Belpre

Belpre, Ohio, 45714

Bowling Green, Ohio

Status

Address

Toledo Clinic Cancer Centers-Bowling Green

Bowling Green, Ohio, 43402

Adena Regional Medical Center, Chillicothe, Ohio

Status

Address

Adena Regional Medical Center

Chillicothe, Ohio, 45601

Oncology Hematology Care Inc-Eden Park, Cincinnati, Ohio

Status

Address

Oncology Hematology Care Inc-Eden Park

Cincinnati, Ohio, 45202

Oncology Hematology Care Inc-Mercy West, Cincinnati, Ohio

Status

Address

Oncology Hematology Care Inc-Mercy West

Cincinnati, Ohio, 45211

Oncology Hematology Care Inc - Anderson, Cincinnati, Ohio

Status

Address

Oncology Hematology Care Inc - Anderson

Cincinnati, Ohio, 45230

Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio

Status

Address

Oncology Hematology Care Inc-Kenwood

Cincinnati, Ohio, 45236

Oncology Hematology Care Inc-Blue Ash, Cincinnati, Ohio

Status

Address

Oncology Hematology Care Inc-Blue Ash

Cincinnati, Ohio, 45242

Columbus, Ohio

Status

Address

Columbus Oncology and Hematology Associates Inc

Columbus, Ohio, 43214

Riverside Methodist Hospital, Columbus, Ohio

Status

Address

Riverside Methodist Hospital

Columbus, Ohio, 43214

Columbus, Ohio

Status

Address

Columbus NCI Community Oncology Research Program

Columbus, Ohio, 43215

Grant Medical Center, Columbus, Ohio

Status

Address

Grant Medical Center

Columbus, Ohio, 43215

The Mark H Zangmeister Center, Columbus, Ohio

Status

Address

The Mark H Zangmeister Center

Columbus, Ohio, 43219

Mount Carmel Health Center West, Columbus, Ohio

Status

Address

Mount Carmel Health Center West

Columbus, Ohio, 43222

Doctors Hospital, Columbus, Ohio

Status

Address

Doctors Hospital

Columbus, Ohio, 43228

Good Samaritan Hospital - Dayton, Dayton, Ohio

Status

Address

Good Samaritan Hospital - Dayton

Dayton, Ohio, 45406

Miami Valley Hospital, Dayton, Ohio

Status

Address

Miami Valley Hospital

Dayton, Ohio, 45409

Samaritan North Health Center, Dayton, Ohio

Status

Address

Samaritan North Health Center

Dayton, Ohio, 45415

Delaware, Ohio

Status

Address

Delaware Health Center-Grady Cancer Center

Delaware, Ohio, 43015

Delaware Radiation Oncology, Delaware, Ohio

Status

Address

Delaware Radiation Oncology

Delaware, Ohio, 43015

Grady Memorial Hospital, Delaware, Ohio

Status

Address

Grady Memorial Hospital

Delaware, Ohio, 43015

Oncology Hematology Care Inc-Healthplex, Fairfield, Ohio

Status

Address

Oncology Hematology Care Inc-Healthplex

Fairfield, Ohio, 45014

Blanchard Valley Hospital, Findlay, Ohio

Status

Address

Blanchard Valley Hospital

Findlay, Ohio, 45840

Franklin, Ohio

Status

Address

Atrium Medical Center-Middletown Regional Hospital

Franklin, Ohio, 45005-1066

Wayne Hospital, Greenville, Ohio

Status

Address

Wayne Hospital

Greenville, Ohio, 45331

Kettering Medical Center, Kettering, Ohio

Status

Address

Kettering Medical Center

Kettering, Ohio, 45429

Fairfield Medical Center, Lancaster, Ohio

Status

Address

Fairfield Medical Center

Lancaster, Ohio, 43130

Lima Memorial Hospital, Lima, Ohio

Status

Address

Lima Memorial Hospital

Lima, Ohio, 45804

Marietta Memorial Hospital, Marietta, Ohio

Status

Address

Marietta Memorial Hospital

Marietta, Ohio, 45750

OneHealth Marion General Hospital, Marion, Ohio

Status

Address

OneHealth Marion General Hospital

Marion, Ohio, 43302

Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio

Status

Address

Toledo Clinic Cancer Centers-Maumee

Maumee, Ohio, 43537

Maumee, Ohio

Status

Address

Toledo Radiation Oncology at Northwest Ohio Onocolgy Center

Maumee, Ohio, 43537

Knox Community Hospital, Mount Vernon, Ohio

Status

Address

Knox Community Hospital

Mount Vernon, Ohio, 43050

Licking Memorial Hospital, Newark, Ohio

Status

Address

Licking Memorial Hospital

Newark, Ohio, 43055

Newark Radiation Oncology, Newark, Ohio

Status

Address

Newark Radiation Oncology

Newark, Ohio, 43055

Saint Charles Hospital, Oregon, Ohio

Status

Address

Saint Charles Hospital

Oregon, Ohio, 43616

Toledo Clinic Cancer Centers-Oregon, Oregon, Ohio

Status

Address

Toledo Clinic Cancer Centers-Oregon

Oregon, Ohio, 43616

Southern Ohio Medical Center, Portsmouth, Ohio

Status

Address

Southern Ohio Medical Center

Portsmouth, Ohio, 45662

Springfield Regional Medical Center, Springfield, Ohio

Status

Address

Springfield Regional Medical Center

Springfield, Ohio, 45505

Flower Hospital, Sylvania, Ohio

Status

Address

Flower Hospital

Sylvania, Ohio, 43560

Mercy Hospital of Tiffin, Tiffin, Ohio

Status

Address

Mercy Hospital of Tiffin

Tiffin, Ohio, 44883

Saint Vincent Mercy Medical Center, Toledo, Ohio

Status

Address

Saint Vincent Mercy Medical Center

Toledo, Ohio, 43608

University of Toledo, Toledo, Ohio

Status

Address

University of Toledo

Toledo, Ohio, 43614

Toledo, Ohio

Status

Address

Toledo Community Hospital Oncology Program CCOP

Toledo, Ohio, 43617

Mercy Saint Anne Hospital, Toledo, Ohio

Status

Address

Mercy Saint Anne Hospital

Toledo, Ohio, 43623

Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio

Status

Address

Toledo Clinic Cancer Centers-Toledo

Toledo, Ohio, 43623

Upper Valley Medical Center, Troy, Ohio

Status

Address

Upper Valley Medical Center

Troy, Ohio, 45373

Fulton County Health Center, Wauseon, Ohio

Status

Address

Fulton County Health Center

Wauseon, Ohio, 43567

Saint Ann's Hospital, Westerville, Ohio

Status

Address

Saint Ann's Hospital

Westerville, Ohio, 43081

Zanesville, Ohio

Status

Address

Genesis Healthcare System Cancer Care Center

Zanesville, Ohio, 43701

Oklahoma City, Oklahoma

Status

Address

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104

Tulsa, Oklahoma

Status

Address

Oklahoma Cancer Specialists and Research Institute-Tulsa

Tulsa, Oklahoma, 74146

Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania

Status

Address

Lehigh Valley Hospital-Cedar Crest

Allentown, Pennsylvania, 18103

Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania

Status

Address

Lehigh Valley Hospital - Muhlenberg

Bethlehem, Pennsylvania, 18017

Harrisburg, Pennsylvania

Status

Address

PinnacleHealth Cancer Center-Community Campus

Harrisburg, Pennsylvania, 17109

Reading Hospital, West Reading, Pennsylvania

Status

Address

Reading Hospital

West Reading, Pennsylvania, 19611

Easley, South Carolina

Status

Address

Greenville Health System Cancer Institute-Easley

Easley, South Carolina, 29640

Greenville, South Carolina

Status

Address

Greenville Health System Cancer Institute-Andrews

Greenville, South Carolina, 29605

Greenville, South Carolina

Status

Address

Greenville Health System Cancer Institute-Butternut

Greenville, South Carolina, 29605

Greenville, South Carolina

Status

Address

Greenville Health System Cancer Institute-Faris

Greenville, South Carolina, 29605

Greenville Memorial Hospital, Greenville, South Carolina

Status

Address

Greenville Memorial Hospital

Greenville, South Carolina, 29605

Greenville, South Carolina

Status

Address

Greenville Health System Cancer Institute-Eastside

Greenville, South Carolina, 29615

Greer, South Carolina

Status

Address

Greenville Health System Cancer Institute-Greer

Greer, South Carolina, 29650

Seneca, South Carolina

Status

Address

Greenville Health System Cancer Institute-Seneca

Seneca, South Carolina, 29672

Spartanburg, South Carolina

Status

Address

Greenville Health System Cancer Institute-Spartanburg

Spartanburg, South Carolina, 29307

Rapid City Regional Hospital, Rapid City, South Dakota

Status

Address

Rapid City Regional Hospital

Rapid City, South Dakota, 57701

University Medical Center Brackenridge, Austin, Texas

Status

Address

University Medical Center Brackenridge

Austin, Texas, 78701

Dallas, Texas

Status

Address

UT Southwestern/Simmons Cancer Center-Dallas

Dallas, Texas, 75390

Salt Lake City, Utah

Status

Address

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, 84112

University of Virginia Cancer Center, Charlottesville, Virginia

Status

Address

University of Virginia Cancer Center

Charlottesville, Virginia, 22908

Fredericksburg Oncology Inc, Fredericksburg, Virginia

Status

Address

Fredericksburg Oncology Inc

Fredericksburg, Virginia, 22401

Gundersen Lutheran Medical Center, La Crosse, Wisconsin

Status

Address

Gundersen Lutheran Medical Center

La Crosse, Wisconsin, 54601

Madison, Wisconsin

Status

Address

University of Wisconsin Hospital and Clinics

Madison, Wisconsin, 53792

Community Memorial Hospital, Menomonee Falls, Wisconsin

Status

Address

Community Memorial Hospital

Menomonee Falls, Wisconsin, 53051

Milwaukee, Wisconsin

Status

Address

Froedtert and the Medical College of Wisconsin

Milwaukee, Wisconsin, 53226

ProHealth D N Greenwald Center, Mukwonago, Wisconsin

Status

Address

ProHealth D N Greenwald Center

Mukwonago, Wisconsin, 53149

Cancer Center of Western Wisconsin, New Richmond, Wisconsin

Status

Address

Cancer Center of Western Wisconsin

New Richmond, Wisconsin, 54017

ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin

Status

Address

ProHealth Oconomowoc Memorial Hospital

Oconomowoc, Wisconsin, 53066

ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin

Status

Address

ProHealth Waukesha Memorial Hospital

Waukesha, Wisconsin, 53188

Rocky Mountain Oncology, Casper, Wyoming

Status

Address

Rocky Mountain Oncology

Casper, Wyoming, 82609

Big Horn Basin Cancer Center, Cody, Wyoming

Status

Address

Big Horn Basin Cancer Center

Cody, Wyoming, 82414

Billings Clinic-Cody, Cody, Wyoming

Status

Address

Billings Clinic-Cody

Cody, Wyoming, 82414

Welch Cancer Center, Sheridan, Wyoming

Status

Address

Welch Cancer Center

Sheridan, Wyoming, 82801